<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005402A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005402</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14016399</doc-number><date>20130903</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><priority-claims><priority-claim sequence="01" kind="regional"><country>EP</country><doc-number>03405080.7</doc-number><date>20030212</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>215</main-group><subgroup>14</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>215</main-group><subgroup>14</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>546173</main-classification></classification-national><invention-title id="d0e61">CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>13664498</doc-number><date>20121031</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8557993</doc-number></document-id></parent-grant-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14016399</doc-number></document-id></child-doc></relation></continuation><continuation><relation><parent-doc><document-id><country>US</country><doc-number>13280431</doc-number><date>20111025</date></document-id><parent-status>ABANDONED</parent-status></parent-doc><child-doc><document-id><country>US</country><doc-number>13664498</doc-number></document-id></child-doc></relation></continuation><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12331086</doc-number><date>20081209</date></document-id><parent-status>ABANDONED</parent-status></parent-doc><child-doc><document-id><country>US</country><doc-number>13280431</doc-number></document-id></child-doc></relation></continuation><continuation><relation><parent-doc><document-id><country>US</country><doc-number>10544752</doc-number><date>20050808</date></document-id><parent-status>ABANDONED</parent-status><parent-pct-document><document-id><country>WO</country><doc-number>PCT/EP2004/050066</doc-number><date>20040202</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>12331086</doc-number></document-id></child-doc></relation></continuation></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>NISSAN CHEMICAL INDUSTRIES, LTD.</orgname><address><city>Tokyo</city><country>JP</country></address></addressbook><residence><country>JP</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>VAN DER SCHAAF</last-name><first-name>Paul Adriaan</first-name><address><city>Hagenthal-le-Haut</city><country>FR</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Blatter</last-name><first-name>Fritz</first-name><address><city>Reinach</city><country>CH</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Szelagiewicz</last-name><first-name>Martin</first-name><address><city>Muenchenstein</city><country>CH</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Schoening</last-name><first-name>Kai-Uwe</first-name><address><city>Oberwil</city><country>CH</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>NISSAN CHEMICAL INDUSTRIES, LTD.</orgname><role>03</role><address><city>Tokyo</city><country>JP</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention is directed to new crystalline forms of Pitavastatin hemicalcium salt, referred to hereinafter as polymorphic Forms A, B, C, D, E and F, as well as the amorphous form. Furthermore, the present invention is directed to processes for the preparation of these crystalline forms and the amorphous form and pharmaceutical compositions comprising these crystalline forms or the amorphous forms.</p></abstract></us-patent-application>